Skip to content

6 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Oct 2026

Landscape of small molecules derived from marine sources and their clinical progression.

The review is put forth to discuss key advancements in landscapes of small molecules derived from marine sources, along with their clinical status, and key challenges in marine drug discovery, such as access to marine organisms, supply chain sustainability, chemical diversity, synthesis complexity, bioavailability opti...

Murugesan Vanangamudi, A. Jain, Thakur Gurjeet Singh et al. · 0 citations
Sep 2026

Associations of Plant- and Animal-Sourced Ultra-Processed Foods and Incident CKD in the Cardiovascular Health Study.

BACKGROUND Ultra-processed foods (UPFs) are associated with adverse health. Plant foods can be highly processed. It is not clear whether plant- and animal-sourced UPFs are associated chronic kidney disease (CKD) risk. METHODS Data came from the Cardiovascular Health Study, a prospective cohort of 2,661 older adults (...

Courtney M. Hill, Alyssa Feinberg, Casey M. Rebholz et al. · 0 citations
Open access Aug 2026

From solutions to living systems: a colorimetric and “turn-on” chemosensor for Co2+ with paper-strip and bioimaging applications

5-(4-Chlorophenoxy)-3-methyl-1-phenyl-1H-pyrazole-4-carbaldehyde (PYA), a pyrazole-based fluorescent chemosensor, was synthesised and studied for the selective detection of Co2+ ions. With exceptional selectivity over other metal ions that are relevant to biology and the environment, the sensor displays a clear “turn-o...

A. R. Nesaragi, Jyoti Nagalik, Thakur Gurjeet Singh et al. · 0 citations
Review Open access Sep 2026

ASN Kidney Health Guidance on the Cardiovascular-Kidney-Metabolic Syndrome.

KEY POINTS The cardiovascular-kidney-metabolic (CKM) syndrome framework has important implications in the care of people with kidney diseases. Cardiovascular screening is important in people with kidney diseases, but the approach may differ in this high-risk population. Multiple pharmacotherapies for CKM syndrome offer...

N. Bansal, P. Bjornstad, A. Bress et al. · 3 citations
Review Aug 2026

Personalizing cardiovascular prevention in chronic kidney disease: an operational framework for risk-treatment mapping.

Patients with chronic kidney disease (CKD) bear a disproportionate burden of cardiovascular (CV) morbidity and mortality, yet preventive strategies in clinical practice remain remarkably conservative and largely therapy-centered. The 2024 KDIGO guideline on CKD evaluation and management advocates the systematic use of...

Carmine Zoccali, C. Kovesdy, F. Mallamaci et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.